Clinical Trial Update: Allopregnanolone for the Treatment of Traumatic Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of allopregnanolone for traumatic brain injury has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Epilepsy
• Traumatic Brain Injury

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Michael A. Rogawski, MD, PhD | Conditions: Traumatic Brain Injury, Posttraumatic Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2017-06-28